Loading…
This event has ended. Visit the official site or create your own event on Sched.
SYMPOSIUM THEME
Hemoglobin S - Making an Evolutionary Perfected Process, Imperfect 

Journal of Sickle Cell Disease and Hemoglobinoopathies
SYMPOSIUM ABSTRACTS

Meeting Location:

Greater Ft. Lauderdale Convention Center
1950 Eisenhower Blvd, Fort Lauderdale, Florida, USA  33316
April 28 - 30, 2017 
Website:  fscdr.org
Email:  symposium@fscdr.org
Is this a CME Medical Meeting?  Yes
 
View analytic
Saturday, April 29 • 4:00pm - 6:00pm
Nursing Matters

Sign up or log in to save this to your schedule and see who's attending!

Yvonne M. Carroll, RN, JD: Moderator
Dr. Ken Bridges : (Global Blood Therapeutics  - GBT440 – oral polymerization inhibitor)
Dr. Rosa Real: (Prolong Pharmaceuticals - Sanguinate™ - bovine blood substitute)
Dr. Gary Fortin: (Bluebird Bio  - gene therapy)
Dr. Fernando Tricta: (Apopharma  -  Ferriprox™ - oral chelator)


Moderators
avatar for Yvonne M. Carroll, RN, JD

Yvonne M. Carroll, RN, JD

Director of Patient Services, Hematology, St. Jude Children’s Research Hospital
Yvonne M. Carroll, RN, JD is the Director of Patient Services in the Department of Hematology at St. Jude Children’s Research Hospital.  Yvonne graduated with a Bachelors of Nursing Degree from the University of Tennessee and a Law degree from the University of Cincinnati. She joined SJCRH in 1999 in the Department of Hematology and served in several positions before becoming the Director of Patient... Read More →

Speakers
avatar for Fernando Tricta, M.D.

Fernando Tricta, M.D.

Vice-President, Medical Affairs, ApoPharma, Inc.
Dr. Fernando Tricta, is a pediatric hematologist/oncologist, with a particular interest in hemoglobinopathies and iron metabolism. He was head of the Hemoglobinopathies Program at Pediatric Hem/Onc Research Center at the University of Campinas, Brazil, and worked at the University of Turin... Read More →
avatar for Kenneth R. Bridges, M.D.

Kenneth R. Bridges, M.D.

Vice President, Medical Affairs, Global Blood Therapeutics
Dr. Kenneth R. Bridges received the MD degree from Harvard Medical School, and subsequently trained in internal medicine and hematology in Boston, at Massachusetts General and Brigham and Women’s Hospitals, respectively. Following medical subspecialty training, Dr. Bridges worked on the biology of cellular iron metabolism for three years at the National Institutes of Health in Bethesda, Maryland. Dr. Bridges returned to Harvard as a member of the Hematology Division at Brigham and... Read More →
avatar for Rosa Real, M.D.

Rosa Real, M.D.

Head of North American Clinical Operations, Prolong Pharmaceuticals
Dr. Rosa Real is currently the Head of North American Clinical Operations at Prolong Pharmaceuticals. In this role, she oversees the clinical development and execution of clinical trials across Prolong’s portfolio of products, with special interest in the Sickle Cell Disease protocol titled... Read More →
avatar for Gary Fortin, Ph.D.

Gary Fortin, Ph.D.

Senior Director, Medical Affairs, Bluebird Bio
As Senior Director, Medical Affairs at bluebird bio, Gary Fortin, PhD, oversees the development and execution of global medical affairs strategy across the company’s gene therapy portfolio with products in development for childhood CNS disease and hemoglobinopathies.   Prior to joining bluebird in September 2015, Gary held various pharmaceutical and biotechnology positions supporting both development-stage and commercialized products in nephrology, neurology, and benign and malignant... Read More →


Saturday April 29, 2017 4:00pm - 6:00pm
305 North Lobby 3rd Floor